RANBP9 and Alzheimer disease: Taken together these results indicate that RanBPM has a pathological role in the major hallmarks contributing to AD: Aβ production and decreased synaptic function and density, neuronal death contributing to neurological defects, and can even accelerate disease pathology, indicating that RanBPM may be a therapeutic target for AD [110].